Adrenocorticotropic hormone for the treatment of West syndrome in children;Hormona adrenocorticotrópica (ACTH) para el tratamiento del síndrome de West en niños

Annals of Pharmacotherapy

Volumn 47, Issue 5, 2013, Pages 744-754

  Shumiloff, Nicole A ^a   Lam, Weng Man ^b   Manasco, Kalen B ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b Georgia Regents Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; CORTICOSTEROID; CORTICOTROPIN; PREDNISONE; PYRIDOXINE; VIGABATRIN; ZONISAMIDE;

ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; CHILDHOOD DISEASE; CUSHING SYNDROME; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPSARRHYTHMIA; INFANTILE SPASM; INFECTION; IRRITABILITY; KIDNEY FAILURE; LIVER FAILURE; LOW DRUG DOSE; MUSCLE SPASM; NERVE CELL DIFFERENTIATION; OBESITY; PRIORITY JOURNAL; SIDE EFFECT; SLEEP DISORDER; SYSTEMATIC REVIEW; THRUSH; WEIGHT GAIN; WEST SYNDROME;

EID: 84877097431     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R535     Document Type: Article

References (33)

1. Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 2001;23:539-41.
2. Ludvigsson P, Olafsson E, Sigurdardottir S, Hauser WA. Epidemiological features of infantile spasms in Iceland. Epilepsia 1994;35:802-5.
3. Trevathan E, Murphy CC, Yeargin-Allsopp M. The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 1999;40:748-51.
4. Cowen LD, Hudson LS. The epidemiology and natural history of infantile spasms. J Child Neurol 1991;6:355-64.
5. Product information. H.P. ACTHAR GEL for intramuscular/subcutaneous injection, repository corticotropin gel for intramuscular/subcutaneous injection. Hayward, CA: Questcor Pharmaceuticals, Inc., June 2011.
6. Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms: report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2012;78: 1974-80. doi:10.1212/WNL.0b013e318259e2cf
7. Yanagaki S, Oguni H, Hayashi K, et al. A comparative study of high-dose and low-dose ACTH therapy for West syndrome. Brain Dev 1999;21:461-7.
8. Hrachovy RA, Frost JD Jr, Glaze DG. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr 1994;124:803-6.
9. Hamano SI, Yamashita S, Tanaka M, Yoshinari S, Minamitani M, Eto Y. Therapeutic efficacy and adverse effects of adrenocorticotropic hormone therapy in West syndrome: differences in dosage of adrenocorticotropic hormone, onset of age, and cause. J Pediatr 2006;148:485-8. doi: 10.1016/j.peds.2005.11.041
10. Ito M, Aiba H, Hashimoto K, et al. Low-dose ACTH therapy for West syndrome: initial effects and long-term outcome. Neurology 2002;58:110-4.
11. Kondo Y, Okumura A, Watanabe K, et al. Comparison of two low dose ACTH therapies for West syndrome: their efficacy and side effect. Brain Dev 2005;27:326-30. doi: 10.1016/j.braindev.2004.09.003
12. Oguni H, Yanagaki S, Hayashi K, et al. Extremely low-dose ACTH step-up protocol for West syndrome: maximum therapeutic effect with minimal side effects. Brain Dev 2006;28:8-13.
13. Ito M, Miyajima T, Fujii T, Okuno T. Subdural hematoma during lowdose ACTH therapy in patients with West syndrome. Neurology 2000; 54:2346-7.
14. Vigevano F, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997;38:1270-4.
15. Ibrahim S, Gulab S, Ishaque S, Saleem T. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH-a developing country perspective. BMC Pediatr 2010;10:1-9. doi:10.1186/1471-2431-10-1
16. Cossette P, Riviello JJ, Carmant L. ACTH versus vigabatrin in infantile spasms: a retrospective study. Neurology 1999;52:1691-4.
17. Baram TZ, Mitchell WG, Tournay A, Snead OC III, Hanson RA, Horton EJ. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatr 1996;97:375-9.
18. Hrachovy RA, Frost JD Jr, Kellaway P, et al. Double blind study of ACTH vs prednisone therapy in infantile spasms. J Pediatr 1983;103:641-5.
19. Kossoff EH, Hartman AL, Rubenstein JE, Vining EPG. High-dose prednisolone for infantile spasms: an effective and less expensive alternative to ACTH. Epilepsy Behav 2009;14:674-6. doi: 10.1016/j.yebeh.2009.01.023
20. Kossoff EH, Hedderick EF, Turner Z, Freeman JM. A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia 2008;49:1504-9. doi:10.1111/j.1528-1167.2008.01606.x
21. Cohen-Sadan S, Kramer U, Ben-Zeev B, et al. Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin. Eur J Neurol 2009;16:482-7. doi:10.1111/j.1468-1331.2008.02498.x
22. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicenter, randomised controlled trial. Lancet 2004;364:1773-8.
23. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005;4:712-7. doi: 10.1016/51474-4422(05)70199-X
24. Drug topics red book: pharmacy's fundamental resource, 2012 edition. Montvale, NJ: Thomson Medical Economics, 2012.
25. Wray CD, Benke TA. Effect of price increase of adrenocorticotropic hormone on treatment practices of infantile spasms. Pediatr Neurol 2010;43: 163-6. doi:10.1016/j.pediatrneurol.2010.04.005
26. Gettig J, Cummings JP, Matuszewski K. H.P. Acthar gel and cosyntropin review: clinical and financial implications. PT 2009;34:250-7.
27. Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a US consensus report. Epilepsia 2010;51:2175-89. doi: 10, 111/j.1528-1167.2010.02657.x
28. Product information. Cortrosyn (cosyntropin) injection, powder for solution. Rancho Cucamonga, CA: Amphastar Pharmaceuticals, Inc., September 2005.
29. Product information. Sabril (vigabatrin) for oral solution, tablets. Deerfield, IL: Lundbeck, November 2011.
30. Ann & Robert H Lurie Children's Hospital of Chicago. Prevention of West syndrome with low-dose adrenocorticotrophin hormone (ACTH) (PREVENT-WS). Bethesda, MD: National Library of Medicine (US), 2011. ClinicalTrials. gov http://clinicaltrials.gov/show/NCT01367964 NLM (accessed 2012 Oct 29).
31. Watemberg N. Infantile spasms: treatment challenges. Curr Treat Options Neurol 2012;14:322-31. doi:10.1007/s11940-012-0181-x
32. Silverman SB. The 2011 EB Hershberg award for important discoveries in medicinally active substances: 1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms. J Med Chem 2012; 96:172-5. doi: 10.1021/jm201650r
33. Raffo E, Coppola A, Ono T, Briggs SW, Galanopoulou AS. A pulse rap-amy cin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis 2011;43:322-39. doi: 10.1016/j.nbd.2011.03.021